流式检测PNH克隆的方法学探讨及临床筛检和意义 <sup>*</sup>

doi:10.13523/j.cb.20190905

中国生物工程杂志

2019, Vol. 39

Issue (9): 33-40 DOI: 10.13523/j.cb.20190905

研究报告

流式检测PNH克隆的方法学探讨及临床筛检和意义 ^*

袁晓英,王亚哲,石韦华,常艳,郝乐,贺玲玲,石红霞,黄晓军,刘艳荣(

)

北京大学人民医院北京大学血液病研究所国家血液系统疾病临床医学研究中心北京 100044

Methodological Study on Flow Detection of PNH Clone and Its Clinical Screening Significance

YUAN Xiao-ying,WANG Ya-zhe,SHI Wei-hua,CHANG Yan,HAO Le,HE Ling-ling,SHI Hong-xia,HUANG Xiao-jun,LIU Yan-rong(

)

Peking University Peoples’Hospital, Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease, Beijing 100044, China

全文: PDF(2289 KB) HTML

摘要：

目的: 探讨流式细胞仪高敏感方法检测PNH克隆的必要性和血细胞减少患者PNH克隆的发生率及临床意义。方法: 采用CD59检测红细胞及FLAER联合CD24或CD14检测粒细胞和单核细胞的方法检测了20例健康志愿者和1 095例血细胞减少患者的PNH克隆比例,同时对31例患者采用传统的CD59方法检测粒细胞和单核细胞中CD59 ^-细胞比例。 结果： 根据健康志愿者正常背景和患者获取的细胞数,确定粒细胞、单核细胞和红细胞PNH克隆的最低检测限(LOD)分别为0.04%、0.10%和0.05%;827例患者FLAER ^-CD24 ^-粒细胞、FLAER ^-CD14 ^-单核细胞和CD59 ^-红细胞的中位比例分别为0.02%、0.02%和0.03%;318例(38.45%)患者粒细胞PNH克隆高于LOD,180例FLAER ^-CD24 ^-粒细胞<1.00%,粒红和粒单细胞的一致性只有43%~45%。138例FLAER ^-CD24 ^-粒细胞≥1.00%,粒红、粒单和粒单红细胞的一致率分别为91.30%、97.83%和89.86%;比较CD59 ^-和FLAER ^-CD24 ^-粒细胞、CD59 ^-和FLAER ^-CD14 ^-单核细胞比例,CD59 ^-细胞比例明显更低(P<0.000 1和P=0.000 9);26.85%和24.54%患者因出现FLAER ^-CD24 ⁺粒细胞与FLAER ^-CD14 ⁺单核细胞,导致FLAER单阴比例高于FLAER和锚连蛋白双阴比例,对PNH克隆比例低于0.10%的患者影响更大;36例PNH患者和50例MDS或AA患者PNH克隆比例分别为90.30%(44.49%~99.05%)和1.30%(0.10%~96.07%)(P<0.000 1);PNH克隆比例等于41.81%时,诊断PNH的敏感度和特异度分别为100.0%和96.0%。 结论： 在本实验条件下根据正常背景值,确定粒细胞、红细胞的LOD分别为0.04%和0.05%。粒细胞PNH克隆比例≥1.00%,与单核和红细胞诊断PNH克隆阳性结果更一致,PNH克隆比例高于41.81%时PNH疾病可能性更大。

关键词： PNH克隆; 嗜水气单胞菌溶素变异体(FLAER); 流式细胞仪

Abstract:

Objective: To explore the importance and clinical indications of high-sensitivity assay detecting PNH clones by flow cytometry and the incidence and clinical significance of PNH clones in patients with hematopenia.Methods: FLAER combined with CD24 or CD14 was used to detect the percentage of PNH clones in granulocytes and monocytes, and CD59 was used to detect the percentage of PNH clones in erythrocytes of 20 healthy volunteers and 1 095 patients with hematopenia. Meanwhile, CD59 negative percentage in granulocytes and monocytes of 31 patients was detected by traditional CD59 method.Results: According to background of volunteers and numbers of cells, limited of detection (LOD) of granulocytes, monocytes and erythrocytes were 0.04%, 0.10% and 0.05%, respectively. The median percentages of FLAER ^-CD24 ^- granulocytes, FLAER ^-CD14 ^- monocytes and CD59 ^- erythrocytes were 0.02%, 0.02% and 0.03% in 827 patients, separately. The proportions of PNH clones in granulocytes were above LOD in 318 patients. Among of 180 patients with PNH clones below 1.00%, the consistent rates of granulocytes with monocytes and erythrocytes were from 43% to 45%. When the percentages of PNH clones in granulocytes were more than 1.00%, the consistency rates of granulocytes with monocytes and erythrocytes were around 90.00%. Comparing the percentage of CD59 negative granulocytes and monocytes with that of FLAER and anchor protein double negative, the former was significantly lower than the latter (P< 0.000 1 and P=0.000 9). The percentages of FLAER single negative granulocytes were higher than that of FLAER and anchor protein double negative cells in 26.85% patients. The similar results occured in monocytes of 24.54% patients. The patients with PNH clones below 0.10% were affected more easily. PNH clones were 90.30% (44.49%~99.05%) in 36 patients with PNH and 1.30% (0.10%~96.07%) in 50 patients with MDS or AA, separately (P<0.000 1). When PNH clone was 41.81%, the sensitivity and specificity of PNH diagnosis were 100.0% and 96.0%, respectively. Conclusion: In this study, the LOD of granulocyte and erythrocyte was 0.04% and 0.05% respectively. When the proportion of PNH clones in granulocytes is more than 1.00%, the positive results of monocytes and erythocytes are more consistent. PNH disease is more likely when the proportion of PNH clones is higher than 41.81%.

Key words: PNH clone FLAER Flow cytometry

收稿日期: 2019-09-04 出版日期: 2019-09-20

ZTFLH:

Q291

基金资助: * 国家重大科学仪哭设备开发专项(2011YQ03013407)

通讯作者: 刘艳荣 E-mail: yrliu163@163.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	袁晓英
	王亚哲
	石韦华
	常艳
	郝乐
	贺玲玲
	石红霞
	黄晓军
	刘艳荣

引用本文:

袁晓英,王亚哲,石韦华,常艳,郝乐,贺玲玲,石红霞,黄晓军,刘艳荣. 流式检测PNH克隆的方法学探讨及临床筛检和意义 ^*[J]. 中国生物工程杂志, 2019, 39(9): 33-40.

YUAN Xiao-ying,WANG Ya-zhe,SHI Wei-hua,CHANG Yan,HAO Le,HE Ling-ling,SHI Hong-xia,HUANG Xiao-jun,LIU Yan-rong. Methodological Study on Flow Detection of PNH Clone and Its Clinical Screening Significance. China Biotechnology, 2019, 39(9): 33-40.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190905 或 https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I9/33

图1 红细胞、粒细胞和单核细胞PNH克隆检测设门策略

表1 粒细胞PNH克隆不同比例时单核和红细胞PNH克隆分布(N=827)

图2 FLAER联合锚连蛋白和CD59方法检测粒细胞和单核细胞PNH克隆的相关性

图3 FLAER+锚连蛋白双阴和CD59单阴的配对比较

图4 PNH和MDS/AA患者PNH克隆比例的ROC曲线

[1]	Parker C J . Historical aspects of paroxysmal nocturnal haemoglobinuria: ‘Defining the disease’. Br J Haematol, 2002,117(1):3-22.
[2]	Parker C J . Bone marrow failure syndromes: Paroxysmal nocturnal hemoglobinuria. Hematol Oncol Clin North Am, 2009,23(2):333-346.
[3]	Parker C, Omine M, Richards S , et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood, 2005,106(12):3699-3709.
[4]	Borowitz M J, Craig F E, DiGiuseppe J A, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom, 2010,78(4):211-230.
[5]	中华医学会血液学分会. 骨髓增生异常综合征诊断与治疗专家共识. 中华血液学杂志, 2012,33(4):347-352.
	Chinese Society of Hematology . The diagnosis and treatment of myelodysplastic syndrome. Chinese Journal of Hematology, 2012,33(4):347-352.
[6]	Marsh J C, Ball S E, Cavenagh J , et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol, 2009,147(1):43-70.
[7]	Hernández-Campo P M, Almeida J, Sánchez M L , et al. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom, 2006,70(2):71-81.
[8]	Brodsky R A, Mukhina G L, Li S , et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol, 2000,114(3):459-466.
[9]	Hernández-Campo P M, Almeida J, Matarraz S , et al. Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow. Cytometry B Clin Cytom, 2007 , 72(1):34-42.
[10]	Richards S J, Whitby L, Cullen M J , et al. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry. Cytometry B Clin Cytom, 2009,76(1):47-55.
[11]	杨柯, 郭晓宇, 欧剑锋 , 等. 外周血粒细胞CD55, CD59和FLAER检测在贫血及PNH诊断中的意义. 现代检验医学杂志, 2017,32(3):6-10.
	Yang K, Guo X Y, OU J F , et al. Diagnostic significance of detecting peripheral blood granulocyte CD55/CD59 and FLAER in anemia and PNH. Journal of Modern Laboratory Medicine, 2017,32(3):6-10.
[12]	梁悦怡, 谢守军 . FLAER多参数检测PNH克隆的意义. 国际检验医学杂志, 2016,37(8):1139-1141.
	Liang Y Y, Xie S J . FLAER multiparameter detection PNH cloning significance. International Journal of Laboratory Medicine, 2016,37(8):1139-1141.
[13]	Olteanu H, Karandikar N J, McKenna R W, et al.Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol, 2006,126(5):781-788.

[1]	张明陆阳清卢克焕. 牛分离精子对其IVF胚胎染色体影响的研究[J]. 中国生物工程杂志, 2007, 27(1): 98-101.
[2]	叶玲玲, 刘红, 李世崇, 刘兴茂, 吴本传, 陈昭烈. 用YO-PRO-1和PI联合染色定量检测细胞凋亡[J]. 中国生物工程杂志, 2005, 25(10): 50-53,62.

Viewed

Full text

Abstract

Cited

Shared

Discussed